The Global Market for Commercial Biotechnology Separation Systems is Projected to Exceed US$33 Billion by 2020

Robust Biosimilars Market Drives the Commercial Biotechnology Separation Systems Market, According to a New Report by Global Industry Analysts, Inc.

GIA launches comprehensive analysis of industry segments, trends, growth drivers, market share, size and demand forecasts on the global Commercial Biotechnology Separation Systems Market. The global market for Commercial Biotechnology Separation Systems is projected to exceed US$33 billion by 2020, driven by a robustly growing Biosimilars market supported by the strong focus on reducing drug prices and cost of healthcare.  

Biological products are of significant importance in a wide range of sectors including food, cosmetic and pharmaceutical industries. Separating biomolecules and proteins such as RNA and DNA are key processes in commercial production of biotechnology products. These macromolecules are separated from their source material for their use in analysis as well as in production of biotechnological products. While in some applications biological products need little further processing and can be employed as crude extracts, their use in biopharmaceuticals require high levels of purity that make downstream processing with separation and purification steps critical. Separation technology is vital since it plays a major role in influencing product efficacy and ability to achieve regulatory conformance.

Separation processes in the area of biotechnology make use of a wide range of advanced separating systems including liquid chromatography, microarrays, electrophoresis, membrane filtration, flow cytometry and centrifugation technologies, among others. These biotechnology separation systems are used for a wide range of purposes, including production of enzymes, vaccines, insulin and hormones for therapeutic applications in the pharmaceutical industry, along with other uses in applications such as energy and food production. Increasing demand for biotechnology products and technological advances in separation technologies are driving growth in the market. The emergence of the pharmaceutical sector as a high impact end-use sector is fundamentally changing the way these separation devices are built, given the high safety and hygienic requirements in the pharma industry. Liquid chromatography represents the most commonly adopted separation methodology in the area of bioprocessing. From a research-dedicated tool in life sciences, liquid chromatography has evolved to become a key technology in commercial applications of biotechnology.

As stated by the new market research report on Commercial Biotechnology Separation Systems, the United States represents the largest market worldwide. Strong government support of the biosimilars market and effervescent drug pipeline in the biopharmaceutical industry, represent key factors fuelling the country’s dominance. Asia-Pacific ranks as the fastest growing market with a CAGR of 11.7% over the analysis period, led by robust lifesciences and biotechnology research activity, increased understanding of contemporary biotechnology principles and practices, and growing domestic production of drugs, food products and cosmetics.

Key players covered in the report include 3M Purification, Inc., AB Sciex, Affymetrix, Inc., Agilent Technologies, Inc., Alfa Laval AB, Alfa Wassermann Inc., Atoll GmbH, Beckman Coulter, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Flottweg SE, Fluidigm Corporation, GE Healthcare, Groupe Novasep, Hitachi Koki Co., Ltd., Illumina, Inc., Merck KGaA, Pall Corporation, PerkinElmer, Inc., ProMetic Life Sciences, Inc., Repligen Corporation, Sartorius Stedim Biotech SA, SEPMAG Technologies, Shimadzu Scientific Instruments, Spectrum Laboratories, Inc., Sysmex Partec GmbH, and Thermo Fisher Scientific, Inc., among others.

The research report titled “Commercial Biotechnology Separation Systems: A Global Strategic Business Report” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, drivers, mergers, acquisitions and other strategic industry activities of major companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia, and Rest of Europe), Asia-Pacific (China, India, and Rest of Asia-Pacific), Middle East & Africa, and Latin America (Brazil, and Rest of Latin America). The types of separation system analyzed for the global market in the report include DNA Microarray, Flow Cytometry, Liquid Chromatography, Membrane Filtration, Protein Microarray, and Others (includes Biochips, Centrifugation, and Electrophoresis among others).

Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.